AFYREN: Funding, Investors & Team (Sep 2026)
AFYREN is a biotech company dedicated to developing innovative biobased solutions for high value-added compounds with the goal of enabling a low-carbon, circular industry. Our technology is based on a patented biomimetic fermentation process and our production model at our first plant, AFYREN NEOXY, produces 100% biobased acids in a low-carbon, zero-waste biorefinery in France. We work with partners in various industries to create sustainable products that meet market demands, while prioritizing sustainability and minimizing our environmental impact. Join us in our mission to revolutionize the chemical industry through bioeconomy and sustainable innovation!
AFYREN has raised $17.7M across 3 funding rounds on record, the most recent an undisclosed round of $3.5M announced in Apr 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AFYREN Company Profile and Key Stats
Latest funding round on record: Apr 2026.
AFYREN Funding Rounds
AFYREN raised $9.5M in an undisclosed round announced in Nov 2024.
8 months later, an undisclosed round of $4.7M was announced in Jul 2025.
9 months later, an undisclosed round of $3.5M was announced in Apr 2026.
AFYREN Founders and Leadership Team
Contact details for the AFYREN team: 2 of 2 have an email address on file.
Start 14-day free trial →AFYREN Funding Compared to Other Biotechnology Startups
AFYREN's latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AFYREN in Biotechnology and Saint-beauzire
Companies Similar to AFYREN
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
AFYREN Funding FAQs
What does AFYREN do?
AFYREN is a biotech company dedicated to developing innovative biobased solutions for high value-added compounds with the goal of enabling a low-carbon, circular industry. Our technology is based on a patented biomimetic fermentation process and our production model at our first plant, AFYREN NEOXY, produces 100% biobased acids in a low-carbon, zero-waste biorefinery in France. We work with partners in various industries to create sustainable products that meet market demands, while prioritizing sustainability and minimizing our environmental impact. Join us in our mission to revolutionize the chemical industry through bioeconomy and sustainable innovation!
How much funding has AFYREN raised?
AFYREN has raised $17.7M across 3 rounds on record. The most recent is an undisclosed round of $3.5M announced in Apr 2026.
When did AFYREN last raise funding?
AFYREN's most recent funding round on record is an undisclosed round of $3.5M, announced in Apr 2026.
Who founded AFYREN?
FundedIQ lists Jeremy Pessiot (Founder), Nicolas Sordet (Founder) at AFYREN.
Where is AFYREN headquartered?
AFYREN is based in Saint-beauzire, Rhone-Alpes, France.
How many employees does AFYREN have?
AFYREN is in the 11-50 employee band.
How does AFYREN's funding compare to other Biotechnology startups?
AFYREN's latest round of $3.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's AFYREN Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AFYREN is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.